⌘K

07:30:00·1640d

PRReleasevia Quantisnow

Intellia Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress

ByQuantisnow·Wall Street's wire, on your screen.

NTLA· Intellia Therapeutics Inc.

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

NTLA
Intellia Therapeutics Inc.
Health Care

Recent analyst ratings

Mar 2UpdateWilliam Blair-
Nov 12UpdateWolfe Research-
Nov 11UpdateEvercore ISI$8.00
Nov 7UpdateAnalyst$5.00
Oct 28UpdateRBC Capital Mkts$14.00
Oct 28UpdateBernstein-

Related

PR1d
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SEC2d
Intellia Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
SEC2d
SEC Form DEFA14A filed by Intellia Therapeutics Inc.
SEC2d
SEC Form DEF 14A filed by Intellia Therapeutics Inc.
SEC2d
SEC Form 424B5 filed by Intellia Therapeutics Inc.
SEC3d
SEC Form SCHEDULE 13G filed by Intellia Therapeutics Inc.
PR3d
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
SEC4d
SEC Form 424B5 filed by Intellia Therapeutics Inc.